In vitro synergistic activities of tobramycin and selected β-lactams against 75 gram-negative clinical isolates

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2586-2588

  Owens Jr , Robert C ^a,b,c   Banevicius, Mary Anne ^d   Nicolau, David P ^d   Nightingale, Charles H ^d   Quintiliani, Richard ^d  

^a MEDICAL CENTER OF DELAWARE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c UNIVERSITY OF THE SCIENCES   (United States)

^d HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TOBRAMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CITROBACTER FREUNDII; DRUG POTENTIATION; ENTEROBACTER CLOACAE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS;

EID: 0343145712     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2586     Document Type: Article

References (25)

1. Andriole, V. T. 1971. Synergy of carbenacillin and gentamicin in experimental infection with pseudomonas. J. Infect. Dis. 124:S46-S55.
2. Andriole, V. T. 1974. Antibiotic synergy in experimental infection with pseudomonas. II. The effect of carbenacillin, cephalothin, or cephanone combined with tobramycin or gentamicin. J. Infect. Dis. 129:124-133.
3. Archer, G., and F. R. Fekety, Jr. 1977. Experimental endocarditis due to Pseudomonas aeruginosa. II. Therapy with carbenacillin and gentamicin. J. Infect. Dis. 136:327-335.
4. Barriere, S. L. 1992. Bacterial resistance to β-lactams, and its prevention with combination antimicrobial therapy. Pharmacotherapy 12:397-402.
5. Bodey, G. P., R. Feld, and M. A. Burgess. 1976. β-Lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients. Am. J. Med. Sci. 271:179-186.
6. Bodey, G. P., L. Jadeja, and L. Elting. 1985. Pseudomonas bacteremia retrospective analysis of 410 episodes. Arch. Intern. Med. 145:1621-1629.
7. Durack, D. T., L. L. Pelletier, and R. G. Petersdorf. 1974. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci. J. Clin. Invest. 53:829-833.
8. Elion, G. B., S. Singer, and G. H. Hitchings. 1954. Antagonists of nucleic acid derivatives: synergism in combinations of biochemically related antimetabolites. J. Biol. Chem. 208:477-488.
9. Eliopoulos, G. M., and R. C. Moellering. 1991. Antimicrobial combinations, p. 330-396. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. The Williams and Wilkins Co., Baltimore, Md.
10. Gribble, M. J., A. W. Chow, S. C. Naiman, J. A. Smith, W. R. Bowie, S. L. Sacks, L. Grossman, N. Buskard, G. H. Growe, and L. H. Plenderleith. 1983. Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections. Antimicrob. Agents Chemother. 24:388-393.
11. Haltander, H. O., K. Dornbusch, L. Gezelius, K. Jacobson, and I. Karlsson. 1982. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob. Agents Chemother. 22:743-752.
12. Hilf, M., V. L. Yu, J. Sharp, J. J. Zuravleff, J. A. Korvick, and R. R. Muder. 1989. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am. J. Med. 87:540-546.
13. Klastersky, J., R. Cappel, and D. Daneau. 1972. Clinical significance of in vitro synergism between antibiotics in gram-negative infections. Antimicrob. Agents Chemother. 2:470-475.
14. Klastersky, J., A. Henri, C. Hensgens, and D. Daneau. 1974. Gram-negative infections in cancer. Study of empiric therapy comparing carbenacillin-cephalothin with and without gentamicin. JAMA 227:45-48.
15. Korvick, J. A., and V. L. Yu. 1991. Antimicrobial agent therapy for Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 35:2167-2172.
16. Moellering, R. C., Jr. Antimicrobial synergism - an elusive concept. 1979. J. Infect. Dis. 140:639-641. (Editorial.)
17. Owens, R. C., Jr., M. A. Banevicius, D. P. Nicolau, C. H. Nightingale, and R. Quintiliani. 1997. Evaluation of in-vitro synergy between tobramycin and selected beta-lactams, abstr. A-151, p. 27. In Abstracts of the 97th General Meeting of the American Society for Microbiology, American Society for Microbiology, Washington, D.C.
18. Rand, K. H., H. J. Houck, P. Brown, and D. Bennett. 1993. Reproducibility of the microdilution checkerboard method for antibiotic synergy. Antimicrob. Agents Chemother. 37:613-615.
19. Reyes, M. P., M. R. El-Khatib, W. J. Brown, F. Smith, and A. M. Lerner. 1979. Synergy between carbenacillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum. J. Infect. Dis. 140:192-202.
20. Sande, M. A., and R. G. Irvin. 1974. Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis. J. Infect. Dis. 129:572-576.
21. Sanders, C. C., and W. E. Sanders. 1983. Emergence of resistance during therapy with the newer β-lactam antibiotics: role of inducible β-lactamases and implications for the future. Rev. Infect. Dis. 5:639-648.
22. Scheld, W. M., D. D. Fletcher, F. N. Fink, and M. A. Sande. 1979. Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. J. Infect. Dis. 140:287-294.
23. Waitz, J. A., G. V. Doern, S. M. Finegold, T. L. Gavan, J. L. Hackett, R. N. Jones, J. H. Jorgensen, J. R. King, G. H. Miller, L. B. Reller, C. Thornsberry, L. D. Thrupp, and R. J. Zabransky. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed., p. 1-32. NCCLS document M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
24. Wilson, W. R., J. E. Geraci, C. J. Wilkowske, and J. A. Washington. 1978. Short-term intramuscular therapy with procaine penicillin plus streptomycin for infective endocarditis due to viridans streptococci. Circulation 57:1158-1161.
25. Wilson, W. R., R. L. Thompson, C. J. Wilkowske, and J. A. Washington. 1981. Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. JAMA 245: 360-363.